Soft Tissue Sarcoma New Reference: Botensilimab / Balstilimab for Metastatic Sarcomas Ulas D. Bayraktar, MD 2025-04-22
Breast Cancer New Protocol: Metronomic Capecitabine with Aromatase Inhibitors in Metastatic Breast Cancer Ulas D. Bayraktar, MD 2025-04-22
Breast Cancer New Protocol: Eribulin with Trastuzumab-Pertuzumab in First-Line Breast Cancer Ulas D. Bayraktar, MD 2025-04-22
Non-Small Cell Lung Cancer New Indication: Nivolumab – Ipilimumab for Neoadjuvant NSCLC Ulas D. Bayraktar, MD 2025-04-22
Soft Tissue Sarcoma New Protocol: Regorafenib Maintenance for Sarcoma Ulas D. Bayraktar, MD 2025-04-22
Non-Small Cell Lung Cancer New Reference: Taletrectinib for ROS1-Positive NSCLC Ulas D. Bayraktar, MD 2025-04-22
GastroEsophageal Cancer New Reference: NOTCH1 Mutation as a Predictive Marker for Tislelizumab Ulas D. Bayraktar, MD 2025-04-22
Bladder Cancer New Reference: Sacituzumab Govitecan for Advanced Urothelial Carcinoma Ulas D. Bayraktar, MD 2025-04-07
Diffuse Large B Cell Lymphoma New Protocol: Brentuximab-Rituximab-Lenalidomide for Large Cell Lymphoma Ulas D. Bayraktar, MD 2025-04-07
